Global X - Genomics and Biotechnology ETF (GNOM) |
| 66.02 0.11 (0.17%) 10-15 10:06 |
| Open: | 65.21 |
| High: | 66.39 |
| Low: | 64.55 |
| Volume: | 4,584 |
| Market Cap: | 100(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 74.19 |
| Resistance 1: | 69.62 |
| Pivot price: | 68.24 |
| Support 1: | 62.22 |
| Support 2: | 51.77 |
| 52w High: | 74.191 |
| 52w Low: | 41.16 |
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 12 Oct 2026
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Wed, 07 Oct 2026
The Best-Performing ETFs for Norwegian Investors - Morningstar
Fri, 11 Sep 2026
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
Thu, 10 Sep 2026
7 Best Biotech ETFs to Buy Now | Investing - U.S. News - Money
Wed, 19 Aug 2026
Healthcare ETFs rally as Moderna nearly doubles on melanoma win - Seeking Alpha
Wed, 12 Aug 2026
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
